[Methylene blue in surgery of primary hyperparathyroidism]. (1998)

Peer-Reviewed Study · Robert J, Delay D, Buhler L, Garcia A, Spilipoulos A · April 1998

Robert J et al., 1998-04: French retrospective study of 175 consecutive patients operated for primary hyperparathyroidism over 20 years, comparing operating times with and without preoperative intravenous methylene blue.

This retrospective study compares the durations of interventions for primary hyperparathyroidism carried out after i.v. MB administration to those when no MB was given.

23-6

Robert J et al., 1998-04: French retrospective study of 175 consecutive patients operated for primary hyperparathyroidism over 20 years, comparing operating times with and without preoperative intravenous methylene blue. C6 France (Ann Endocrinol (Paris) 59(1):23-6). Study type: retrospective comparative study, N=175 (55 operated before February 1986 when methylene blue was introduced routinely, 120 after; 32 excluded). Route: intravenous methylene blue preoperatively; dose not in the abstract. Comparator: historical controls operated before routine methylene blue use – a before/after design, so secular trends (technique, staffing) are not controlled. Funder/conflicts: none declared. PubMed indexes this record with publication type 'Clinical Trial' although the design is retrospective. Study type: controlled study.